相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between HDL-C levels and menopause: a meta-analysis
Hongwei Li et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2021)
Statin therapy and sex hormones
Cosimo Andrea Stamerra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Crosstalk between Oxidative Stress and Inflammation in Obesity
Mirela Elena Epingeac et al.
REVISTA DE CHIMIE (2020)
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Seong-Hee Ko et al.
NUTRIENTS (2020)
Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
Sarah Davis et al.
HEALTH TECHNOLOGY ASSESSMENT (2020)
Cardiovascular Risk and Statin Therapy Considerations in Women
Gina Gheorghe et al.
DIAGNOSTICS (2020)
Relationship between high-density lipoprotein cholesterol levels and endothelial function in women: a cross-sectional study
Yuji Takaeko et al.
BMJ OPEN (2020)
Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis
Haiyan Meng et al.
NUTRITION (2020)
The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats
Mohammad Navid Ebrahimi et al.
LIFE SCIENCES (2020)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Impact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial
Somaye Fatahi et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2018)
Antiosteoporotic effect of Hemidesmus indicus Linn. on ovariectomised rats
Sharad Desai et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Hypertriglyceridaemia and risk of coronary artery disease
Zeljko Reiner
NATURE REVIEWS CARDIOLOGY (2017)
Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Gianna Ferretti et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients The GLAGOV Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Aromatase expression and regulation in breast and endometrial cancer
Hong Zhao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Efficacy of Raloxifene Hydrochloride for the Prevention of Health Care Problems in Patients Who Undergo Surgery for Endometrial Cancer A Multicenter Randomized Clinical Trial
Koji Nakamura et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials
John C. Stevenson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions
Panagiotis Anagnostis et al.
MATURITAS (2015)
Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers
Susan B. Brown et al.
STEROIDS (2015)
Estrogen accelerates the resolution of inflammation in macrophagic cells
Alessandro Villa et al.
SCIENTIFIC REPORTS (2015)
Estrogen or Raloxifene during Postmenopausal Weight Loss: Adiposity and Cardiometabolic Outcomes
R. E. Van Pelt et al.
OBESITY (2014)
Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women
Fernando Grover-Paez et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: Subgroup analysis of a double-blind randomized controlled trial
C. C. Mok et al.
LUPUS (2013)
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
Davide Serrano et al.
BREAST CANCER RESEARCH (2013)
Cholesterol metabolism and resistance to tamoxifen
Marc Poirot et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment
Tina Trdan Lusin et al.
TRANSLATIONAL RESEARCH (2012)
Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial
Chi Chiu Mok et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Randomized, controlled study of the effects of raloxifene on high sensitivity C-reactive protein and serum lipids
Efser Oztas et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2011)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of raloxifene treatment on the phenotype of blood monocytes
Karim Zouaoui Boudjeltia et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Effects of Raloxifene on Brachial Arterial Endothelial Function, Carotid Wall Thickness, and Arterial Stiffness in Osteoporotic Postmenopausal Women
Hiroyuki Sumino et al.
INTERNATIONAL HEART JOURNAL (2010)
Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency
Manuel Naves-Diaz et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Effects of raloxifene on serum macrophage colony-stimulating factor and interleukin-18 levels in postmenopausal women younger than 60 years
Efser Oztas et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women
Toshiyuki Yasui et al.
ATHEROSCLEROSIS (2009)
The Residual Risk Reduction Initiative: a call to action to residual vascular risk in dyslipidaemic patients
Jean-Charles Fruchart et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Role of raloxifene on platelet metabolism and plasma lipids
L. Nanetti et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Raloxifene has favourable effects on metabolic parameters but has no effect on left ventricular function in postmenopausal women
Mesut Oktem et al.
PHARMACOLOGICAL RESEARCH (2008)
Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women
D. L. Katz et al.
CLIMACTERIC (2007)
Raloxifene slows down the progression of intima-media thickness in postmenopausal women
Nicola Colacurci et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Effect of raloxifene - a selective oestrogen receptor modulator - on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial
S. Hadjadj et al.
DIABETIC MEDICINE (2007)
Exonic, but not intronic polymorphisms of ESR1 gene might influence the hypolipemic effect of raloxifene
Andrei Zavratnik et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Effects of intranasal 17β-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women:: A randomized, placebo-controlled clinical trial
Yaprak Engin-Ustun et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Pleiotropic effects of statins: Benefit beyond cholesterol reduction? A meta-regression analysis
JG Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women
MF Yildiz et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2005)
Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women
TE Vogelvang et al.
MATURITAS (2005)
Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women
AR Dias et al.
CLIMACTERIC (2005)
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women
A Lasco et al.
DIABETOLOGIA (2004)
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene
S Palomba et al.
HUMAN REPRODUCTION (2004)
Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
SM Grundy et al.
CIRCULATION (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease
KA Griffiths et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis
E Hernández et al.
KIDNEY INTERNATIONAL (2003)
Endothelial function and menopause: Effects of raloxifene administration
N Colacurci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women
A Cagnacci et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
分享论文
